Acquired Thrombotic Thrombocytopenic Purpura
8 clinical trials · Condition
◉ Watch Acquired Thrombotic Thrombocytopenic Purpura
| Record | Firm | Date |
|---|---|---|
| Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP (NCT04985318) | University of Cologne | 2021-03-25 |
| A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP) (NCT04021173) | Lee's Pharmaceutical Limited | 2019-07-01 |
| Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES) (NCT02878603) | Sanofi | 2016-10-06 |
| Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura (NCT02553317) | Ablynx, a Sanofi company | 2015-11-01 |
| Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) (NCT01151423) | Ablynx, a Sanofi company | 2011-01-01 |
Track Acquired Thrombotic Thrombocytopenic Purpura automatically
Every clearance here is in the API, with alerts when new ones post.